Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

TLV:TKUN Revenue

In the year 2025, Tikun Olam-Cannbit Pharmaceuticals had annual revenue of 9.10M ILS, down -73.96%. Tikun Olam-Cannbit Pharmaceuticals had revenue of 14.10M in the half year ending December 31, 2024, a decrease of -49.90%.

• Revenue: 9.10M
• Revenue Growth: -79.02%
• P/S Ratio: 1.50
• Revenue / Employee: 2.28M
• Employees: 19
• Market Cap: 13.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.10M	-25.85M	-73.96%
Dec 31, 2024	34.95M	-9.28M	-20.97%
Dec 31, 2023	44.23M	-5.07M	-10.28%
Dec 31, 2022	49.30M	12.27M	33.13%
Dec 31, 2021	37.03M	15.37M	70.97%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 15, 2026

Data Sources Report a data error